ENZY up +11.14% percent Today $ENZY High is at 8.16 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 12:19 PM

ENZY up +11.14% percent Today $ENZY High is at 8.16 and the Low 7.32 with current volume of 93,515.

Recent News posted below.

Enzymotec Ltd ENZY other info.
http://investorshangout.com/Enzymotec-Ltd-ENZY-90540/

ENZY Enzymotec Ltd Recent Headline News

Enzymotec's (ENZY) CEO Dr. Ariel Katz on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 12:50PM CST

ENZY: 8.28 (+1.01)

Enzymotec beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:34AM CST

ENZY: 8.28 (+1.01)

Enzymotec Ltd. Reports Third Quarter 2014 Unaudited Financial Results
GlobeNewswire - Thu Nov 13, 6:30AM CST
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported its financial results for the third quarter ended September 30, 2014.
ENZY: 8.28 (+1.01)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 4:30PM CST

KSS: 57.63 (+0.51), VTNR: 4.77 (-0.22), TYC: 42.48 (+0.08), SPH: 44.34 (-0.32), FLY: 13.21 (-0.02), ENZY: 8.28 (+1.01), RWLK: 27.46 (-0.44), WMT: 83.43 (+0.47), RSTI: 26.62 (+0.45), SBH: 29.96 (-0.27), HP: 77.85 (-1.16), GIB: 36.66 (+0.45), TDG: 192.23 (-0.22), CLFD: 13.14 (+0.64), HIMX: 6.96 (-0.16), VIAB: 74.48 (+1.52), MMS: 52.53 (-0.04)

Enzymotec Ltd. Initiates Clinical Study of Vayarin(R) in Adult ADHD
GlobeNewswire - Tue Nov 11, 7:38AM CST
Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer, and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, today announced the initiation of a clinical study to evaluate the efficacy of Vayarin(R) in adults with Attention Deficit Hyperactivity Disorder, or ADHD.
ENZY: 8.28 (+1.01)

Enzymotec to Report Third Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Thu Oct 30, 7:30AM CDT
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the Company will release financial results for the third quarter ended September 30, 2014 on Thursday, November 13, 2014, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer will host a conference call to review the financial results.
ENZY: 8.28 (+1.01)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Involving Enzymotec Ltd. and a Lead Plaintiff Deadline of November 4, 2014 -- ENZY
GlobeNewswire - Wed Oct 29, 11:17AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"

(NASDAQ:ENZY) that all purchasers of the Company's securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period"

, have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
ENZY: 8.28 (+1.01)

NOV. 4th DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014
Business Wire - Mon Oct 27, 2:45PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"

(Nasdaq:ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 8.28 (+1.01)

Which Stocks Hurt Billionaire Portfolios the Most in 2014?
at The Street - Mon Oct 27, 7:48AM CDT
See the stocks that have performed the worst for 19 billionaires who made their money investing.
BID: 40.45 (-0.75), CBI: 53.38 (-0.81), MDR: 4.21 (-0.07), DLIA: 0.10 (-0.01), EOPN: 6.54 (-0.12), PGEM: 12.35 (-0.17), ENZY: 8.28 (+1.01), GNC: 43.02 (-0.32), AMCC: 6.00 (-0.11), HHC: 143.04 (-0.64), LL: 54.01 (-1.20), VLTC: 1.37 (unch), CZR: 15.77 (-0.73), SNSS: 2.49 (+0.82), TWER: 1.45 (unch), SHOS: 14.27 (+0.03), DRYS: 1.41 (unch), CREE: 34.94 (-0.63)

ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd. -- ENZY
GlobeNewswire - Sat Oct 25, 4:49PM CDT
Kahn Swick & Foti, LLC ("KSF"

and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq:ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO"

on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period"

. This action is pending in the United States District Court for the District of New Jersey.
ENZY: 8.28 (+1.01)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014
Business Wire - Tue Oct 21, 11:52AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"

(NASDAQ:ENZY) pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period"

, have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
ENZY: 8.28 (+1.01)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014 -- ENZY
PR Newswire - Mon Oct 06, 1:33PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"

(Nasdaq: ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 8.28 (+1.01)

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Enzymotec Ltd. to Contact Brower Piven Before the November 4, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ENZY
GlobeNewswire - Sat Oct 04, 7:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company"

(Nasdaq:ENZY) securities pursuant and/or traceable to the Company's Registration Statement and Prospectus ("Offering Documents"

issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period"

.
ENZY: 8.28 (+1.01)

ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Fri Oct 03, 5:22PM CDT
Kahn Swick & Foti, LLC ("KSF"

and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq: ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO"

on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period"

. This action is pending in the United States District Court for the District of New Jersey.
ENZY: 8.28 (+1.01)

EQUITY ALERT: The Rosen Law Firm Reminds Enzymotec Ltd. Investors of Important Class Action Deadline -- ENZY
GlobeNewswire - Thu Oct 02, 1:13PM CDT
The Rosen Law Firm reminds purchasers of Enzymotec Ltd. securities (Nasdaq:ENZY) during the period from September 27, 2013 through August 4, 2014, of the important November 4, 2014 class action deadline.
ENZY: 8.28 (+1.01)

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Enzymotec Ltd.
GlobeNewswire - Tue Sep 30, 3:01PM CDT
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Enzymotec Ltd. ("Enzymotec" or the "Company"

and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 or violated the Securities Act of 1933.
ENZY: 8.28 (+1.01)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Enzymotec Ltd. (ENZY) To Contact The Firm
PR Newswire - Fri Sep 26, 6:30PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Enzymotec Ltd. ("Enzymotec" or the "Company"

(NASDAQ: ENZY) of the November 4, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Enzymotec, certain executives and directors of Enzymotec, and the underwriters of the Company's initial public offering.
ENZY: 8.28 (+1.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palmdale Propane Expands with Affordable Gas Buy

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Factory-Built Homes Take Center Stage in New Doc Short

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Montage Partners Maintains its Founder-Friendly Status

A Streak That Speaks Volumes Did you catch the latest from Scottsdale? Montage Partners, that people-first private equity outfit, just notched its sixth straight year on Inc.'s Founder-Friendly Investors list. Not something you snag with a casual handshake or flimsy promises—this accolade is about real, boots-on-the-ground partnership. Apparently, 294 firms made the...

Unity Crucial for Global South's Economic Gains

Anytime you hear the 'Global South' being bandied about these days, you know someone's talking about the clout shifting in the world. In Beijing this week, they were hashing out how these nations can crank up their collective volume on the global stage. Gathering Brains in Beijing At the Global Strategic Dialogue 2026, held slap-bang in Beijing, experts and high-profile...

E. Coli Outbreaks Spark Push for New Petting Zoo Laws

A Long-Standing Question Finally Answered There comes a time when asking the same question repeatedly feels like chasing your own tail. That's where Bill Marler, food safety attorney extraordinaire, found himself after two decades of wondering if petting zoos should face the chopping block. Right on the heels of E. coli investigations across Illinois, California, and...

2026 Global Ocean Forum Unveils Key Marine Strategies

Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...

AI Identity Fraud Forces New Screening Tactics in Hiring

AI and Identity Fraud: A New Hiring Challenge Piling up futuristic gadgets and tech has made hiring more like a cat and mouse game lately. You'd think checking someone's background would shut the case, but tech-savvy fraudsters have other plans. Employers are up against AI-generated shenanigans and identity theft that are making the business of verifying who exactly...

7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Rivercrest Unveils Inclusive Playground for All Kids

A New Playground Sparks Joy in Wilson, Arkansas The idea of building a playground sounds simple enough, right? But when Rivercrest School District decided to make it happen, they went all in. We’re not just talking swings and slides here. This $507,000 space at Rivercrest Elementary School is an inclusive haven where kids with different needs can just be kids, thanks to...

CaringKind Merger Expands Alzheimer's Care in NY

A New Chapter for Dementia Care: The CaringKind Merger Cornerstone local relationships plus a fresh westerly breeze of national presence—that's the gist of the recent union between CaringKind and Alzheimer's Disease Resource Center. This isn't just a big deal for families in Nassau and Suffolk counties, it's a seismic shift for dementia care reaching across state...